Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy

Narsireddy Amreddy,1,2 Ranganayaki Muralidharan,1,2 Anish Babu,1,2 Meghna Mehta,2,3 Elyse V Johnson,4 Yan D Zhao,2,5 Anupama Munshi,2,3 Rajagopal Ramesh1,2,6 1Department of Pathology, 2Stephenson Cancer Center, 3Department of Radiation Oncology University of Oklahoma Health Sciences Center, Oklahom...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Amreddy N, Muralidharan R, Babu A, Mehta M, Johnson EV, Zhao YD, Munshi A, Ramesh R
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/b370ec7e044142548938ea3bc220c120
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:b370ec7e044142548938ea3bc220c120
record_format	dspace
spelling	oai:doaj.org-article:b370ec7e044142548938ea3bc220c1202021-12-02T01:50:38ZTumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy1178-2013https://doaj.org/article/b370ec7e044142548938ea3bc220c1202015-10-01T00:00:00Zhttps://www.dovepress.com/tumor-targeted-and-ph-controlled-delivery-of-doxorubicin-using-gold-na-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Narsireddy Amreddy,1,2 Ranganayaki Muralidharan,1,2 Anish Babu,1,2 Meghna Mehta,2,3 Elyse V Johnson,4 Yan D Zhao,2,5 Anupama Munshi,2,3 Rajagopal Ramesh1,2,6 1Department of Pathology, 2Stephenson Cancer Center, 3Department of Radiation Oncology University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA; 4CytoViva Inc., Auburn, AL, USA; 5Department of Biostatistics and Epidemiology, 6Graduate Program in Biomedical Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA Background: In lung cancer, the efficacy of conventional chemotherapy is limited due to poor drug accumulation in tumors and nonspecific cytotoxicity. Resolving these issues will increase therapeutic efficacy.Methods: GNR-Dox-Tf-NPs (gold nanorod-doxorubicin-transferrin-nanoparticles) were prepared by different chemical approaches. The efficacy of these nanoparticles was carried out by cell viability in lung cancer and primary coronary artery smooth muscle cells. The receptor-mediated endocytosis studies were done with human transferrin and desferrioxamine preincubation. The GNR-Dox-Tf nanoparticles induced apoptosis, and DNA damage studies were done by Western blot, H2AX foci, and comet assay.Results: We developed and tested a gold nanorod-based multifunctional nanoparticle system (GNR-Dox-Tf-NP) that carries Dox conjugated to a pH-sensitive linker and is targeted to the transferrin receptor overexpressed in human lung cancer (A549, HCC827) cells. GNR-Dox-Tf-NP underwent physicochemical characterization, specificity assays, tumor uptake studies, and hyperspectral imaging. Biological studies demonstrated that transferrin receptor-mediated uptake of the GNR-Dox-Tf-NP by A549 and HCC827 cells produced increased DNA damage, apoptosis, and cell killing compared with nontargeted GNR-Dox-NP. GNR-Dox-Tf-NP-mediated cytotoxicity was greater (48% A549, 46% HCC827) than GNR-Dox-NP-mediated cytotoxicity (36% A549, 39% HCC827). Further, GNR-Dox-Tf-NP markedly reduced cytotoxicity in normal human coronary artery smooth muscle cells compared with free Dox.Conclusion: Thus, GNR-Dox-Tf nanoparticles can selectively target and deliver Dox to lung tumor cells and alleviate free Dox-mediated toxicity to normal cells. Keywords: doxorubicin, gold, lung cancer, nanoparticles, transferrin, tumor targetingAmreddy NMuralidharan RBabu AMehta MJohnson EVZhao YDMunshi ARamesh RDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2015, Iss default, Pp 6773-6788 (2015)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine (General) R5-920
spellingShingle	Medicine (General) R5-920 Amreddy N Muralidharan R Babu A Mehta M Johnson EV Zhao YD Munshi A Ramesh R Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy
description	Narsireddy Amreddy,1,2 Ranganayaki Muralidharan,1,2 Anish Babu,1,2 Meghna Mehta,2,3 Elyse V Johnson,4 Yan D Zhao,2,5 Anupama Munshi,2,3 Rajagopal Ramesh1,2,6 1Department of Pathology, 2Stephenson Cancer Center, 3Department of Radiation Oncology University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA; 4CytoViva Inc., Auburn, AL, USA; 5Department of Biostatistics and Epidemiology, 6Graduate Program in Biomedical Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA Background: In lung cancer, the efficacy of conventional chemotherapy is limited due to poor drug accumulation in tumors and nonspecific cytotoxicity. Resolving these issues will increase therapeutic efficacy.Methods: GNR-Dox-Tf-NPs (gold nanorod-doxorubicin-transferrin-nanoparticles) were prepared by different chemical approaches. The efficacy of these nanoparticles was carried out by cell viability in lung cancer and primary coronary artery smooth muscle cells. The receptor-mediated endocytosis studies were done with human transferrin and desferrioxamine preincubation. The GNR-Dox-Tf nanoparticles induced apoptosis, and DNA damage studies were done by Western blot, H2AX foci, and comet assay.Results: We developed and tested a gold nanorod-based multifunctional nanoparticle system (GNR-Dox-Tf-NP) that carries Dox conjugated to a pH-sensitive linker and is targeted to the transferrin receptor overexpressed in human lung cancer (A549, HCC827) cells. GNR-Dox-Tf-NP underwent physicochemical characterization, specificity assays, tumor uptake studies, and hyperspectral imaging. Biological studies demonstrated that transferrin receptor-mediated uptake of the GNR-Dox-Tf-NP by A549 and HCC827 cells produced increased DNA damage, apoptosis, and cell killing compared with nontargeted GNR-Dox-NP. GNR-Dox-Tf-NP-mediated cytotoxicity was greater (48% A549, 46% HCC827) than GNR-Dox-NP-mediated cytotoxicity (36% A549, 39% HCC827). Further, GNR-Dox-Tf-NP markedly reduced cytotoxicity in normal human coronary artery smooth muscle cells compared with free Dox.Conclusion: Thus, GNR-Dox-Tf nanoparticles can selectively target and deliver Dox to lung tumor cells and alleviate free Dox-mediated toxicity to normal cells. Keywords: doxorubicin, gold, lung cancer, nanoparticles, transferrin, tumor targeting
format	article
author	Amreddy N Muralidharan R Babu A Mehta M Johnson EV Zhao YD Munshi A Ramesh R
author_facet	Amreddy N Muralidharan R Babu A Mehta M Johnson EV Zhao YD Munshi A Ramesh R
author_sort	Amreddy N
title	Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy
title_short	Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy
title_full	Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy
title_fullStr	Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy
title_full_unstemmed	Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy
title_sort	tumor-targeted and ph-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy
publisher	Dove Medical Press
publishDate	2015
url	https://doaj.org/article/b370ec7e044142548938ea3bc220c120
work_keys_str_mv	AT amreddyn tumortargetedandphcontrolleddeliveryofdoxorubicinusinggoldnanorodsforlungcancertherapy AT muralidharanr tumortargetedandphcontrolleddeliveryofdoxorubicinusinggoldnanorodsforlungcancertherapy AT babua tumortargetedandphcontrolleddeliveryofdoxorubicinusinggoldnanorodsforlungcancertherapy AT mehtam tumortargetedandphcontrolleddeliveryofdoxorubicinusinggoldnanorodsforlungcancertherapy AT johnsonev tumortargetedandphcontrolleddeliveryofdoxorubicinusinggoldnanorodsforlungcancertherapy AT zhaoyd tumortargetedandphcontrolleddeliveryofdoxorubicinusinggoldnanorodsforlungcancertherapy AT munshia tumortargetedandphcontrolleddeliveryofdoxorubicinusinggoldnanorodsforlungcancertherapy AT rameshr tumortargetedandphcontrolleddeliveryofdoxorubicinusinggoldnanorodsforlungcancertherapy
_version_	1718402862035238912

Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy

Ejemplares similares